Philip is a research scientist by training with over two decades of experience in fundamental academic and industrial biotech research within diverse fields including oncology, infectious diseases, immunology and immunotherapy. Latterly, he led high-performing teams and high-profile projects in a leading biopharmaceutical firm for biologics drug discovery and development, and he has set up and managed technology platforms in continual pursuit of cutting-edge innovation.

Prior to industry, Philip carried out extensive postdoctoral research in the UK (University of Oxford) and France (CNRS) publishing works in molecular medicine and protein science, employing wide-ranging techniques in biophysics and structural, cellular and molecular biology. Philip also has much experience as a scientific editor and presenter, and he has translated two scientific textbooks from the original French. Philip holds an MSc in Toxicology and a PhD in Biochemistry.